Aurinia Pharmaceuticals Inc.

US$16.46As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AUPHHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 18.40%
Div yield —
ROE 61.42%
Biotechnology
Beta (5Y) 1.34
PE TTM 7.139
TSR TTM 24.98%
Mkt cap US$2.206B
ROIC 71.33%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$20
20.25%
(76.16%)
Hold 6|12|12|8|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.40
0.38
0.40
0.40
24.33%
16.43%
9.58%
(0.34%)
Revenue$M
159.2
159.6
160.8
170.2
16.67%
10.45%
5.61%
6.94%
Peers (US$2.206B)
Cap (US$)
PE
654.6M
—
2.208B
—
Capital
TTM
5Y
10Y
Leveragex
2.459
0.329
0.371
EBIT/Intx
0.428
0.274
0.255
Own earn%
(2.76)
24.13
51.17
Sh yield%
27.73
37.36
37.46
Owners
Insiders/Inst%
4.24
25.70
Short interest%
4.54
SBC / revenue%
2.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
5–11
$1 testx
0.0
Incr. ROIC%
33